Financial toxicity in lung cancer

por Boulanger, Mary, Mitchell, Carley, Zhong, Jeffrey, Hsu, Melinda
Publicado 2022

Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line...

por Ge, Wenzhen, Wu, Ning, Jalbert, Jessica J, Quek, Ruben G W, Liu, Jinjie, Rietschel, Petra, Pouliot, Jean-Francois, Harnett, James, Hsu, Melinda Laine, Feliciano, Josephine L
Publicado 2022

Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune Disease

por Dedousis, Demitrios, Vassiliou, Anastasia N., Cao, Shufen, Yammani, Deepthi, Kyasaram, Ravi K., Shanahan, John, Keinath, Melissa C., Zhang, Annie L., Hsu, Melinda L., Fu, Pingfu, Dowlati, Afshin
Publicado 2022

Survival in elderly patients with breast cancer with and without autoimmune disease

por Dedousis, Demitrios, Zhang, Annie L., Vassiliou, Anastasia N., Cao, Shufen, Yammani, Deepthi, Kyasaram, Ravi K., Shanahan, John P., Keinath, Melissa C., Hsu, Melinda L., Fu, Pingfu, Dowlati, Afshin, Montero, Alberto J.
Publicado 2023

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

por Balaji, Aanika, Hsu, Melinda, Lin, Cheng Ting, Feliciano, Josephine, Marrone, Kristen, Brahmer, Julie R, Forde, Patrick M, Hann, Christine, Zheng, Lei, Lee, Valerie, Illei, Peter B, Danoff, Sonye K, Suresh, Karthik, Naidoo, Jarushka
Publicado 2021

Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy

por Hsu, Melinda L, Murray, Joseph C, Psoter, Kevin J, Zhang, Jiajia, Barasa, Durrant, Brahmer, Julie R, Ettinger, David S, Forde, Patrick M, Hann, Christine L, Lam, Vincent K, Levy, Benjamin, Marrone, Kristen A, Patel, Tricia, Peterson, Valerie, Sagorsky, Sarah, Turner, Michelle, Anagnostou, Valsamo, Naidoo, Jarushka, Feliciano, Josephine L
Publicado 2022